-
1
Among ICU survivors, 10.0% of immunocompromised patients died before hospital discharge, compared with 4.0% of immunocompetent patients.
-
2
Post-ICU deaths accounted for approximately one-half of the absolute difference in in-hospital mortality between immunocompromised and immunocompetent patients.
-
3
The authors note that treatment limitations, late secondary infection, or progression of underlying disease could contribute to excess mortality after ICU discharge.
-
4
The SARI case definition and exclusion of patients with unknown immune status may have affected cohort composition, particularly for COVID-19 admissions.
-
5
Approximately three-quarters of the 11.0-point shortfall in 30-day discharge reflected excess hospital mortality rather than a greater proportion remaining hospitalized.
